Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 47:742-748, doi:10.1016/j.jacc.2005.11.030 (Published online 6 February 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.11.030v1
47/4/742    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwanaga, Y.
Right arrow Articles by Nonogi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwanaga, Y.
Right arrow Articles by Nonogi, H.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: HEART FAILURE

B-Type Natriuretic Peptide Strongly Reflects Diastolic Wall Stress in Patients With Chronic Heart Failure

Comparison Between Systolic and Diastolic Heart Failure

Yoshitaka Iwanaga, MD*,*, Isao Nishi, MD*, Shinichi Furuichi, MD*, Teruo Noguchi, MD*, Kazuhiro Sase, MD*, Yasuki Kihara, MD, FACC{dagger}, Yoichi Goto, MD* and Hiroshi Nonogi, MD*

* Division of Cardiology, National Cardiovascular Center, Suita, Japan
{dagger} Department of Cardiovascular Medicine, Kobe City General Hospital, Kobe, Japan

Manuscript received January 25, 2005; revised manuscript received July 13, 2005, accepted August 22, 2005.

* Reprint requests and correspondence: Dr. Yoshitaka Iwanaga, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoinn-kawaharacho, Kyoto 606-8507, Japan (Email: yiwanaga{at}kuhp.kyoto-u.ac.jp).

OBJECTIVES: We explored the stimulus for B-type natriuretic peptide (BNP) secretion in the clinical setting of heart failure (HF).

BACKGROUND: Increasingly, plasma BNP levels are being incorporated into the clinical assessment and management of systolic heart failure (SHF) as well as diastolic heart failure (DHF). However, heterogeneity in BNP levels among individuals with HF can cause some confusion in interpreting results.

METHODS: In 160 consecutive patients presenting with HF, we measured plasma BNP levels and performed echocardiography and cardiac catheterization. Systolic and diastolic meridional wall stress was calculated from echocardiographic and hemodynamic data.

RESULTS: Although plasma BNP had a significant correlation (r2 = 0.296 [p < 0.001]) with left ventricular end-diastolic pressure (EDP) as previously reported, the correlation between plasma BNP and end-diastolic wall stress (EDWS) (r2 = 0.887 [p < 0.001]) was more robust. In a subanalysis of 62 patients with DHF, a similar result was obtained (r2 = 0.143 for EDP and r2 = 0.704 for EDWS). In a comparison between SHF and DHF, the BNP level was significantly higher in SHF (p < 0.001). Although EDP did not show any difference, EDWS was significantly higher in SHF than in DHF (p < 0.001).

CONCLUSIONS: The present study shows that plasma BNP levels reflect left ventricular EDWS more than any other parameter previously reported, not only in patients with SHF, but also in patients with DHF. The relationship of left ventricular EDWS to plasma BNP may provide a better fundamental understanding of the interindividual heterogeneity in BNP levels and their clinical utility in the diagnosis and management of HF.


Related Article

B-Type Natriuretic Peptide and the Stressed Heart
Anju Nohria and Michael M. Givertz
J. Am. Coll. Cardiol. 2006 47: 749-751. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cleveland Clinic Journal of MedicineHome page
A. IBRAHIM, M. BAIBARS, M. C. ALRAIES, and G. H. OLIVEIRA
Q: Should target natriuretic peptide levels be used for outpatient management of chronic heart failure?
Cleveland Clinic Journal of Medicine, January 1, 2012; 79(1): 22 - 25.
[Full Text] [PDF]


Home page
Circ Heart FailHome page
B. Drexler, C. Heinisch, C. Balmelli, J. Lassus, K. Siirila-Waris, N. Arenja, T. Socrates, M. Noveanu, M. Potocki, C. Meune, et al.
Quantifying Cardiac Hemodynamic Stress and Cardiomyocyte Damage in Ischemic and Nonischemic Acute Heart Failure
Circ Heart Fail, January 1, 2012; 5(1): 17 - 24.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Edelmann, G. Gelbrich, H.-D. Dungen, S. Frohling, R. Wachter, R. Stahrenberg, L. Binder, A. Topper, D. J. Lashki, S. Schwarz, et al.
Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction: Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) Pilot Study
J. Am. Coll. Cardiol., October 18, 2011; 58(17): 1780 - 1791.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
I. S. Anand, T. S. Rector, J. G. Cleland, M. Kuskowski, R. S. McKelvie, H. Persson, J. J. McMurray, M. R. Zile, M. Komajda, B. M. Massie, et al.
Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction: Findings From the I-PRESERVE Trial
Circ Heart Fail, September 1, 2011; 4(5): 569 - 577.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
R. D. Kociol, J. R. Horton, G. C. Fonarow, E. M. Reyes, L. K. Shaw, C. M. O'Connor, G. M. Felker, and A. F. Hernandez
Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes: Data From Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims
Circ Heart Fail, September 1, 2011; 4(5): 628 - 636.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. A. Borlaug and M. M. Redfield
Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum
Circulation, May 10, 2011; 123(18): 2006 - 2014.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. Takase, Y. Dohi, T. Toriyama, T. Okado, S. Tanaka, H. Shinbo, and G. Kimura
B-type natriuretic peptide levels and cardiovascular risk in patients with diastolic dysfunction on chronic haemodialysis: cross-sectional and observational studies
Nephrol. Dial. Transplant., February 1, 2011; 26(2): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
U. Klaar, H. Gabriel, J. Bergler-Klein, E. Pernicka, M. Heger, J. Mascherbauer, R. Rosenhek, T. Binder, G. Maurer, and H. Baumgartner
Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation
Eur J Heart Fail, February 1, 2011; 13(2): 163 - 169.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. S. Velagaleti, P. Gona, M. G. Larson, T. J. Wang, D. Levy, E. J. Benjamin, J. Selhub, P. F. Jacques, J. B. Meigs, G. H. Tofler, et al.
Multimarker Approach for the Prediction of Heart Failure Incidence in the Community
Circulation, October 26, 2010; 122(17): 1700 - 1706.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. T. Maeder, J. A. Mariani, and D. M. Kaye
Hemodynamic Determinants of Myocardial B-Type Natriuretic Peptide Release: Relative Contributions of Systolic and Diastolic Wall Stress
Hypertension, October 1, 2010; 56(4): 682 - 689.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
B. A. Borlaug, R. A. Nishimura, P. Sorajja, C. S. P. Lam, and M. M. Redfield
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Circ Heart Fail, September 1, 2010; 3(5): 588 - 595.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. Biffi, M. Bertini, and G. Boriani
Cardiac resynchronization therapy: is systole all that matters?
Europace, September 1, 2010; 12(9): 1209 - 1210.
[Full Text] [PDF]


Home page
Exp Biol MedHome page
M. Torrado, R. Iglesias, A. Centeno, E. Lopez, and A. T. Mikhailov
Exon-skipping brain natriuretic peptide variant is overexpressed in failing myocardium and attenuates brain natriuretic peptide production in vitro
Exp Biol Med, August 1, 2010; 235(8): 941 - 951.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R. Gurvitch and J. G. Webb
Life after transcatheter aortic valve implantation: quality still matters
Heart, July 1, 2010; 96(14): 1083 - 1084.
[Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
P. A. Gould, L.J. Gula, V. Bhayana, R.N. Subbiah, C. Bentley, R. Yee, G. J. Klein, A. D. Krahn, and A. C. Skanes
Characterization of Cardiac Brain Natriuretic Peptide Release in Patients With Paroxysmal Atrial Fibrillation Undergoing Left Atrial Ablation
Circ Arrhythm Electrophysiol, February 1, 2010; 3(1): 18 - 23.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. A. McCullough and G. S. Hanzel
B-Type Natriuretic Peptide and Echocardiography in the Surveillance of Severe Mitral Regurgitation Prior to Valve Surgery
J. Am. Coll. Cardiol., September 15, 2009; 54(12): 1107 - 1109.
[Full Text] [PDF]


Home page
HeartHome page
M Madhavan, B A Borlaug, A Lerman, C S Rihal, and A Prasad
Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels
Heart, September 1, 2009; 95(17): 1436 - 1441.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Niizuma, Y. Iwanaga, T. Yahata, Y. Tamaki, Y. Goto, H. Nakahama, and S. Miyazaki
Impact of Left Ventricular End-Diastolic Wall Stress on Plasma B-Type Natriuretic Peptide in Heart Failure with Chronic Kidney Disease and End-Stage Renal Disease
Clin. Chem., July 1, 2009; 55(7): 1347 - 1353.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. R. deFilippi and R. H. Christenson
B-Type Natriuretic Peptide (BNP)/NT-proBNP and Renal Function: Is the Controversy Over?
Clin. Chem., July 1, 2009; 55(7): 1271 - 1273.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
R. W. Troughton and A. M. Richards
B-type natriuretic peptides and echocardiographic measures of cardiac structure and function.
J. Am. Coll. Cardiol. Img., February 1, 2009; 2(2): 216 - 225.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Niizuma, Y. Iwanaga, T. Yahata, Y. Goto, T. Kita, S. Miyazaki, and H. Nakahama
Plasma B-type natriuretic peptide levels reflect the presence and severity of stable coronary artery disease in chronic haemodialysis patients
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 597 - 603.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
N. M. Hawkins, M. C. Petrie, P. S. Jhund, G. W. Chalmers, F. G. Dunn, and J. J.V. McMurray
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
Eur J Heart Fail, February 1, 2009; 11(2): 130 - 139.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Maisel, C. Mueller, K. Adams Jr., S. D. Anker, N. Aspromonte, J. G.F. Cleland, A. Cohen-Solal, U. Dahlstrom, A. DeMaria, S. Di Somma, et al.
State of the art: Using natriuretic peptide levels in clinical practice
Eur J Heart Fail, September 1, 2008; 10(9): 824 - 839.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Westermann, M. Kasner, P. Steendijk, F. Spillmann, A. Riad, K. Weitmann, W. Hoffmann, W. Poller, M. Pauschinger, H.-P. Schultheiss, et al.
Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction
Circulation, April 22, 2008; 117(16): 2051 - 2060.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
J. Grewal, R. McKelvie, E. Lonn, P. Tait, J. Carlsson, M. Gianni, C. Jarnert, and H. Persson
BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction
Eur J Heart Fail, March 1, 2008; 10(3): 252 - 259.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. Baumgartner
Neurohormones in valvular heart disease: what can they tell us?
Eur. Heart J., February 1, 2008; 29(3): 290 - 292.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. B. Daniels and A. S. Maisel
Natriuretic Peptides
J. Am. Coll. Cardiol., December 18, 2007; 50(25): 2357 - 2368.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Kurzyna and A. Torbicki
Neurohormonal modulation in right ventricular failure
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H35 - H40.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A. Fijalkowska and A. Torbicki
Role of cardiac biomarkers in assessment of RV function and prognosis in chronic pulmonary hypertension
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H41 - H47.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Breidthardt, K. Laule, A.-H. Strohmeyer, C. Schindler, S. Meier, M. Fischer, A. Scholer, M. Noveanu, M. Christ, A. P. Perruchoud, et al.
Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea
Clin. Chem., August 1, 2007; 53(8): 1415 - 1422.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
L. S. Redwine, P. J. Mills, S. Hong, T. Rutledge, V. Reis, A. Maisel, and M. R. Irwin
Cardiac-related Hospitalization and/or Death Associated With Immune Dysregulation and Symptoms of Depression in Heart Failure Patients
Psychosom Med, January 1, 2007; 69(1): 23 - 29.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Nohria and M. M. Givertz
B-Type Natriuretic Peptide and the Stressed Heart
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 749 - 751.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement